OGN News and Press, Organon & Co. From 05/09/24

2024-05-09 08:15:00 ET Summary Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00. The company reported strong first-quarter results, with increased revenue and growth in key metrics. Teva has a positive business outlook for 2024, w...

2024-05-08 09:10:25 ET Summary Organon released its Q1 2024 results on May 2, and the company's stock has nearly doubled since its low just five months ago. In this update, I take a look at the pharmaceutical and biosimilars company's Q1 earnings report and determine whether the m...

2024-05-08 04:06:42 ET More on Organon Four Reasons Why Organon Stock Is A Good Buy Organon & Co. (OGN) Q1 2024 Earnings Call Transcript Organon Stock Is Still Worth A Look Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue of $1.62B beats by $60M ...

Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...

2024-05-07 12:43:50 ET Summary OGN has underperformed its healthcare peers and the benchmark over the past year, but this could change going forward. The company's dominant women's health product- Nexplanon is looking at double-digit growth in sales this year, even as market loss ...

2024-05-07 08:21:25 ET More on Organon Organon Stock Is Still Worth A Look Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last Read the full article on Seeking Alpha For further details see: Organon plans to offer $1B in senior notes

Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...

2024-05-02 11:53:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Organon (NYSE: OGN ) just reported results for the first quarter of 2024. Organon reported earnings per share of $1.22. This was above the analyst estimate for EPS of 93 c...

2024-05-02 11:09:10 ET Organon & Co. (OGN) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Jennifer Halchak - Vice President, Investor Relations Kevin Ali - Chief Executive Officer Matt Walsh - Chief Financial Officer Confer...

2024-05-02 08:11:46 ET More on Organon Organon Stock Is Still Worth A Look Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last Organon & Co. (OGN) Q4 2023 Earnings Call Transcript Organon Non-GAAP EPS of $1.22 beats by $0.29, revenue ...